ImmuneBridge Inc.

Biotechnology company · San Francisco, California, United States

ImmuneBridge Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $5.6 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

ImmuneBridge at a glance

Typebiotechnology company

HeadquartersSan Francisco, California, United States

Earliest incorporation on record2022

SEC CIK1960306

What does ImmuneBridge do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $5.6 million sold (2025).

Frequently asked questions about ImmuneBridge

Where is ImmuneBridge headquartered?

ImmuneBridge Inc. is headquartered in San Francisco, California, United States.

What does ImmuneBridge do?

ImmuneBridge Inc. is a biotechnology company.

When was ImmuneBridge founded?

The earliest incorporation on record for ImmuneBridge Inc. is in 2022, according to public company registers.

Similar companies

Ossium Health, Inc.San Francisco, California, United States
Vir Biotechnology, Inc.San Francisco, California, United States
Titan Pharmaceuticals IncSan Francisco, California, United States
Senti Biosciences, Inc.San Francisco, California, United States
Amygdala Neurosciences IncSan Francisco, California, United States
Excision BioTherapeutics IncSan Francisco, California, United States
ProLynx, Inc.San Francisco, California, United States
Second Genome, Inc.San Francisco, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences